img

Global Pertuzumab Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pertuzumab Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it blocks heterodimerization of HER2 with other HER receptors, slowing tumor growth.
The global Pertuzumab market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Pertuzumab is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Pertuzumab is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Pertuzumab is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Pertuzumab include Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Pertuzumab, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Pertuzumab by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Pertuzumab market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Pertuzumab market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
By Type
Human Source
Animal Source
By Application
Hospital
Medical Center
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Pertuzumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Pertuzumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertuzumab sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Pertuzumab Definition
1.2 Market by Type
1.2.1 Global Pertuzumab Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Human Source
1.2.3 Animal Source
1.3 Market Segment by Application
1.3.1 Global Pertuzumab Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Medical Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pertuzumab Sales
2.1 Global Pertuzumab Revenue Estimates and Forecasts 2018-2034
2.2 Global Pertuzumab Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Pertuzumab Revenue by Region
2.3.1 Global Pertuzumab Revenue by Region (2018-2023)
2.3.2 Global Pertuzumab Revenue by Region (2024-2034)
2.4 Global Pertuzumab Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Pertuzumab Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Pertuzumab Sales Quantity by Region
2.6.1 Global Pertuzumab Sales Quantity by Region (2018-2023)
2.6.2 Global Pertuzumab Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pertuzumab Sales Quantity by Manufacturers
3.1.1 Global Pertuzumab Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Pertuzumab Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Pertuzumab Sales in 2024
3.2 Global Pertuzumab Revenue by Manufacturers
3.2.1 Global Pertuzumab Revenue by Manufacturers (2018-2023)
3.2.2 Global Pertuzumab Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pertuzumab Revenue in 2024
3.3 Global Pertuzumab Sales Price by Manufacturers
3.4 Global Key Players of Pertuzumab, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pertuzumab, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pertuzumab, Product Offered and Application
3.8 Global Key Manufacturers of Pertuzumab, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pertuzumab Sales Quantity by Type
4.1.1 Global Pertuzumab Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Pertuzumab Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Pertuzumab Sales Quantity Market Share by Type (2018-2034)
4.2 Global Pertuzumab Revenue by Type
4.2.1 Global Pertuzumab Historical Revenue by Type (2018-2023)
4.2.2 Global Pertuzumab Forecasted Revenue by Type (2024-2034)
4.2.3 Global Pertuzumab Revenue Market Share by Type (2018-2034)
4.3 Global Pertuzumab Price by Type
4.3.1 Global Pertuzumab Price by Type (2018-2023)
4.3.2 Global Pertuzumab Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Pertuzumab Sales Quantity by Application
5.1.1 Global Pertuzumab Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Pertuzumab Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Pertuzumab Sales Quantity Market Share by Application (2018-2034)
5.2 Global Pertuzumab Revenue by Application
5.2.1 Global Pertuzumab Historical Revenue by Application (2018-2023)
5.2.2 Global Pertuzumab Forecasted Revenue by Application (2024-2034)
5.2.3 Global Pertuzumab Revenue Market Share by Application (2018-2034)
5.3 Global Pertuzumab Price by Application
5.3.1 Global Pertuzumab Price by Application (2018-2023)
5.3.2 Global Pertuzumab Price Forecast by Application (2024-2034)
6 North America
6.1 North America Pertuzumab Sales by Company
6.1.1 North America Pertuzumab Revenue by Company (2018-2023)
6.1.2 North America Pertuzumab Sales Quantity by Company (2018-2023)
6.2 North America Pertuzumab Market Size by Type
6.2.1 North America Pertuzumab Sales Quantity by Type (2018-2034)
6.2.2 North America Pertuzumab Revenue by Type (2018-2034)
6.3 North America Pertuzumab Market Size by Application
6.3.1 North America Pertuzumab Sales Quantity by Application (2018-2034)
6.3.2 North America Pertuzumab Revenue by Application (2018-2034)
6.4 North America Pertuzumab Market Size by Country
6.4.1 North America Pertuzumab Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Pertuzumab Revenue by Country (2018-2034)
6.4.3 North America Pertuzumab Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pertuzumab Sales by Company
7.1.1 Europe Pertuzumab Sales Quantity by Company (2018-2023)
7.1.2 Europe Pertuzumab Revenue by Company (2018-2023)
7.2 Europe Pertuzumab Market Size by Type
7.2.1 Europe Pertuzumab Sales Quantity by Type (2018-2034)
7.2.2 Europe Pertuzumab Revenue by Type (2018-2034)
7.3 Europe Pertuzumab Market Size by Application
7.3.1 Europe Pertuzumab Sales Quantity by Application (2018-2034)
7.3.2 Europe Pertuzumab Revenue by Application (2018-2034)
7.4 Europe Pertuzumab Market Size by Country
7.4.1 Europe Pertuzumab Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Pertuzumab Revenue by Country (2018-2034)
7.4.3 Europe Pertuzumab Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pertuzumab Sales by Company
8.1.1 China Pertuzumab Sales Quantity by Company (2018-2023)
8.1.2 China Pertuzumab Revenue by Company (2018-2023)
8.2 China Pertuzumab Market Size by Type
8.2.1 China Pertuzumab Sales Quantity by Type (2018-2034)
8.2.2 China Pertuzumab Revenue by Type (2018-2034)
8.3 China Pertuzumab Market Size by Application
8.3.1 China Pertuzumab Sales Quantity by Application (2018-2034)
8.3.2 China Pertuzumab Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Pertuzumab Sales by Company
9.1.1 APAC Pertuzumab Sales Quantity by Company (2018-2023)
9.1.2 APAC Pertuzumab Revenue by Company (2018-2023)
9.2 APAC Pertuzumab Market Size by Type
9.2.1 APAC Pertuzumab Sales Quantity by Type (2018-2034)
9.2.2 APAC Pertuzumab Revenue by Type (2018-2034)
9.3 APAC Pertuzumab Market Size by Application
9.3.1 APAC Pertuzumab Sales Quantity by Application (2018-2034)
9.3.2 APAC Pertuzumab Revenue by Application (2018-2034)
9.4 APAC Pertuzumab Market Size by Region
9.4.1 APAC Pertuzumab Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Pertuzumab Revenue by Region (2018-2034)
9.4.3 APAC Pertuzumab Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pertuzumab Sales by Company
10.1.1 Middle East, Africa and Latin America Pertuzumab Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Pertuzumab Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Pertuzumab Market Size by Type
10.2.1 Middle East, Africa and Latin America Pertuzumab Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Pertuzumab Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Pertuzumab Market Size by Application
10.3.1 Middle East, Africa and Latin America Pertuzumab Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Pertuzumab Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Pertuzumab Market Size by Country
10.4.1 Middle East, Africa and Latin America Pertuzumab Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Pertuzumab Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Pertuzumab Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis AG Pertuzumab Products and Services
11.1.5 Novartis AG Pertuzumab SWOT Analysis
11.1.6 Novartis AG Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Pfizer Pertuzumab Products and Services
11.2.5 Pfizer Pertuzumab SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Abnova Corporation
11.3.1 Abnova Corporation Company Information
11.3.2 Abnova Corporation Overview
11.3.3 Abnova Corporation Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Abnova Corporation Pertuzumab Products and Services
11.3.5 Abnova Corporation Pertuzumab SWOT Analysis
11.3.6 Abnova Corporation Recent Developments
11.4 InvivoGen
11.4.1 InvivoGen Company Information
11.4.2 InvivoGen Overview
11.4.3 InvivoGen Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 InvivoGen Pertuzumab Products and Services
11.4.5 InvivoGen Pertuzumab SWOT Analysis
11.4.6 InvivoGen Recent Developments
11.5 Celltrion
11.5.1 Celltrion Company Information
11.5.2 Celltrion Overview
11.5.3 Celltrion Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Celltrion Pertuzumab Products and Services
11.5.5 Celltrion Pertuzumab SWOT Analysis
11.5.6 Celltrion Recent Developments
11.6 Biocon Limited
11.6.1 Biocon Limited Company Information
11.6.2 Biocon Limited Overview
11.6.3 Biocon Limited Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Biocon Limited Pertuzumab Products and Services
11.6.5 Biocon Limited Pertuzumab SWOT Analysis
11.6.6 Biocon Limited Recent Developments
11.7 Bio-Techne
11.7.1 Bio-Techne Company Information
11.7.2 Bio-Techne Overview
11.7.3 Bio-Techne Pertuzumab Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Bio-Techne Pertuzumab Products and Services
11.7.5 Bio-Techne Pertuzumab SWOT Analysis
11.7.6 Bio-Techne Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pertuzumab Value Chain Analysis
12.2 Pertuzumab Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pertuzumab Production Mode & Process
12.4 Pertuzumab Sales and Marketing
12.4.1 Pertuzumab Sales Channels
12.4.2 Pertuzumab Distributors
12.5 Pertuzumab Customers
13 Market Dynamics
13.1 Pertuzumab Industry Trends
13.2 Pertuzumab Market Drivers
13.3 Pertuzumab Market Challenges
13.4 Pertuzumab Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pertuzumab Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Human Source
Table 3. Major Manufacturers of Animal Source
Table 4. Global Pertuzumab Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Pertuzumab Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Pertuzumab Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Pertuzumab Revenue Market Share by Region (2018-2023)
Table 8. Global Pertuzumab Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Pertuzumab Revenue Market Share by Region (2024-2034)
Table 10. Global Pertuzumab Sales Quantity by Region: 2018 VS 2024 VS 2034 (MT)
Table 11. Global Pertuzumab Sales by Region (2018-2023) & (MT)
Table 12. Global Pertuzumab Sales Market Share by Region (2018-2023)
Table 13. Global Pertuzumab Sales by Region (2024-2034) & (MT)
Table 14. Global Pertuzumab Sales Market Share by Region (2024-2034)
Table 15. Global Pertuzumab Sales Quantity by Manufacturers (2018-2023) & (MT)
Table 16. Global Pertuzumab Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Pertuzumab Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Pertuzumab Revenue Share by Manufacturers (2018-2023)
Table 19. Global Pertuzumab Price by Manufacturers 2018-2023 (USD/MT)
Table 20. Global Key Players of Pertuzumab, Industry Ranking, 2021 VS 2024
Table 21. Global Pertuzumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pertuzumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertuzumab as of 2024)
Table 23. Global Key Manufacturers of Pertuzumab, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pertuzumab, Product Offered and Application
Table 25. Global Key Manufacturers of Pertuzumab, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pertuzumab Sales Quantity by Type (2018-2023) & (MT)
Table 28. Global Pertuzumab Sales Quantity by Type (2024-2034) & (MT)
Table 29. Global Pertuzumab Sales Quantity Share by Type (2018-2023)
Table 30. Global Pertuzumab Sales Quantity Share by Type (2024-2034)
Table 31. Global Pertuzumab Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Pertuzumab Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Pertuzumab Revenue Share by Type (2018-2023)
Table 34. Global Pertuzumab Revenue Share by Type (2024-2034)
Table 35. Pertuzumab Price by Type (2018-2023) & (USD/MT)
Table 36. Global Pertuzumab Price Forecast by Type (2024-2034) & (USD/MT)
Table 37. Global Pertuzumab Sales Quantity by Application (2018-2023) & (MT)
Table 38. Global Pertuzumab Sales Quantity by Application (2024-2034) & (MT)
Table 39. Global Pertuzumab Sales Quantity Share by Application (2018-2023)
Table 40. Global Pertuzumab Sales Quantity Share by Application (2024-2034)
Table 41. Global Pertuzumab Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Pertuzumab Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Pertuzumab Revenue Share by Application (2018-2023)
Table 44. Global Pertuzumab Revenue Share by Application (2024-2034)
Table 45. Pertuzumab Price by Application (2018-2023) & (USD/MT)
Table 46. Global Pertuzumab Price Forecast by Application (2024-2034) & (USD/MT)
Table 47. North America Pertuzumab Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Pertuzumab Sales Quantity by Company (2018-2023) & (MT)
Table 49. North America Pertuzumab Sales Quantity by Type (2018-2023) & (MT)
Table 50. North America Pertuzumab Sales Quantity by Type (2024-2034) & (MT)
Table 51. North America Pertuzumab Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Pertuzumab Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Pertuzumab Sales Quantity by Application (2018-2023) & (MT)
Table 54. North America Pertuzumab Sales Quantity by Application (2024-2034) & (MT)
Table 55. North America Pertuzumab Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Pertuzumab Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Pertuzumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Pertuzumab Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Pertuzumab Sales Quantity by Country (2018-2023) & (MT)
Table 61. North America Pertuzumab Sales Quantity by Country (2024-2034) & (MT)
Table 62. Europe Pertuzumab Sales Quantity by Company (2018-2023) & (MT)
Table 63. Europe Pertuzumab Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Pertuzumab Sales Quantity by Type (2018-2023) & (MT)
Table 65. Europe Pertuzumab Sales Quantity by Type (2024-2034) & (MT)
Table 66. Europe Pertuzumab Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Pertuzumab Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Pertuzumab Sales Quantity by Application (2018-2023) & (MT)
Table 69. Europe Pertuzumab Sales Quantity by Application (2024-2034) & (MT)
Table 70. Europe Pertuzumab Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Pertuzumab Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Pertuzumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Pertuzumab Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Pertuzumab Sales Quantity by Country (2018-2023) & (MT)
Table 76. Europe Pertuzumab Sales Quantity by Country (2024-2034) & (MT)
Table 77. China Pertuzumab Sales Quantity by Company (2018-2023) & (MT)
Table 78. China Pertuzumab Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Pertuzumab Sales Quantity by Type (2018-2023) & (MT)
Table 80. China Pertuzumab Sales Quantity by Type (2024-2034) & (MT)
Table 81. China Pertuzumab Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Pertuzumab Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Pertuzumab Sales Quantity by Application (2018-2023) & (MT)
Table 84. China Pertuzumab Sales Quantity by Application (2024-2034) & (MT)
Table 85. China Pertuzumab Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Pertuzumab Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Pertuzumab Sales Quantity by Company (2018-2023) & (MT)
Table 88. APAC Pertuzumab Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Pertuzumab Sales Quantity by Type (2018-2023) & (MT)
Table 90. APAC Pertuzumab Sales Quantity by Type (2024-2034) & (MT)
Table 91. APAC Pertuzumab Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Pertuzumab Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Pertuzumab Sales Quantity by Application (2018-2023) & (MT)
Table 94. APAC Pertuzumab Sales Quantity by Application (2024-2034) & (MT)
Table 95. APAC Pertuzumab Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Pertuzumab Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Pertuzumab Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Pertuzumab Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Pertuzumab Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Pertuzumab Sales Quantity by Region (2018-2023) & (MT)
Table 101. APAC Pertuzumab Sales Quantity by Region (2024-2034) & (MT)
Table 102. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Company (2018-2023) & (MT)
Table 103. Middle East, Africa and Latin America Pertuzumab Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Type (2018-2023) & (MT)
Table 105. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Type (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Pertuzumab Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pertuzumab Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Application (2018-2023) & (MT)
Table 109. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Application (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Pertuzumab Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pertuzumab Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Pertuzumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Pertuzumab Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Country (2018-2023) & (MT)
Table 116. Middle East, Africa and Latin America Pertuzumab Sales Quantity by Country (2024-2034) & (MT)
Table 117. Novartis AG Company Information
Table 118. Novartis AG Description and Overview
Table 119. Novartis AG Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 120. Novartis AG Pertuzumab Product and Services
Table 121. Novartis AG Pertuzumab SWOT Analysis
Table 122. Novartis AG Recent Developments
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Overview
Table 125. Pfizer Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 126. Pfizer Pertuzumab Product and Services
Table 127. Pfizer Pertuzumab SWOT Analysis
Table 128. Pfizer Recent Developments
Table 129. Abnova Corporation Company Information
Table 130. Abnova Corporation Description and Overview
Table 131. Abnova Corporation Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 132. Abnova Corporation Pertuzumab Product and Services
Table 133. Abnova Corporation Pertuzumab SWOT Analysis
Table 134. Abnova Corporation Recent Developments
Table 135. InvivoGen Company Information
Table 136. InvivoGen Description and Overview
Table 137. InvivoGen Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 138. InvivoGen Pertuzumab Product and Services
Table 139. InvivoGen Pertuzumab SWOT Analysis
Table 140. InvivoGen Recent Developments
Table 141. Celltrion Company Information
Table 142. Celltrion Description and Overview
Table 143. Celltrion Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 144. Celltrion Pertuzumab Product and Services
Table 145. Celltrion Pertuzumab SWOT Analysis
Table 146. Celltrion Recent Developments
Table 147. Biocon Limited Company Information
Table 148. Biocon Limited Description and Overview
Table 149. Biocon Limited Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 150. Biocon Limited Pertuzumab Product and Services
Table 151. Biocon Limited Pertuzumab SWOT Analysis
Table 152. Biocon Limited Recent Developments
Table 153. Bio-Techne Company Information
Table 154. Bio-Techne Description and Overview
Table 155. Bio-Techne Pertuzumab Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 156. Bio-Techne Pertuzumab Product and Services
Table 157. Bio-Techne Pertuzumab SWOT Analysis
Table 158. Bio-Techne Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Pertuzumab Distributors List
Table 162. Pertuzumab Customers List
Table 163. Pertuzumab Market Trends
Table 164. Pertuzumab Market Drivers
Table 165. Pertuzumab Market Challenges
Table 166. Pertuzumab Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertuzumab Product Picture
Figure 2. Global Pertuzumab Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Pertuzumab Market Share by Type in 2024 & 2034
Figure 4. Human Source Product Picture
Figure 5. Animal Source Product Picture
Figure 6. Global Pertuzumab Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Pertuzumab Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Medical Center
Figure 10. Pertuzumab Report Years Considered
Figure 11. Global Pertuzumab Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Pertuzumab Revenue 2018-2034 (US$ Million)
Figure 13. Global Pertuzumab Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Pertuzumab Sales Quantity 2018-2034 (MT)
Figure 15. Global Pertuzumab Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Pertuzumab Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Pertuzumab Sales Quantity YoY (2018-2034) & (MT)
Figure 18. North America Pertuzumab Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Pertuzumab Sales Quantity YoY (2018-2034) & (MT)
Figure 20. Europe Pertuzumab Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Pertuzumab Sales Quantity YoY (2018-2034) & (MT)
Figure 22. China Pertuzumab Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Pertuzumab Sales Quantity YoY (2018-2034) & (MT)
Figure 24. APAC Pertuzumab Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Pertuzumab Sales Quantity YoY (2018-2034) & (MT)
Figure 26. Middle East, Africa and Latin America Pertuzumab Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Pertuzumab Sales Quantity in 2024
Figure 28. The Top 10 and Top 5 Players Market Share by Pertuzumab Revenue in 2024
Figure 29. Pertuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Pertuzumab Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Pertuzumab Revenue Market Share by Type (2018-2034)
Figure 32. Global Pertuzumab Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Pertuzumab Revenue Market Share by Application (2018-2034)
Figure 34. North America Pertuzumab Revenue Market Share by Company in 2024
Figure 35. North America Pertuzumab Sales Quantity Market Share by Company in 2024
Figure 36. North America Pertuzumab Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Pertuzumab Revenue Market Share by Type (2018-2034)
Figure 38. North America Pertuzumab Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Pertuzumab Revenue Market Share by Application (2018-2034)
Figure 40. North America Pertuzumab Revenue Share by Country (2018-2034)
Figure 41. North America Pertuzumab Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Pertuzumab Sales Quantity Market Share by Company in 2024
Figure 45. Europe Pertuzumab Revenue Market Share by Company in 2024
Figure 46. Europe Pertuzumab Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Pertuzumab Revenue Market Share by Type (2018-2034)
Figure 48. Europe Pertuzumab Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Pertuzumab Revenue Market Share by Application (2018-2034)
Figure 50. Europe Pertuzumab Revenue Share by Country (2018-2034)
Figure 51. Europe Pertuzumab Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 53. France Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 57. China Pertuzumab Sales Quantity Market Share by Company in 2024
Figure 58. China Pertuzumab Revenue Market Share by Company in 2024
Figure 59. China Pertuzumab Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Pertuzumab Revenue Market Share by Type (2018-2034)
Figure 61. China Pertuzumab Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Pertuzumab Revenue Market Share by Application (2018-2034)
Figure 63. APAC Pertuzumab Sales Quantity Market Share by Company in 2024
Figure 64. APAC Pertuzumab Revenue Market Share by Company in 2024
Figure 65. APAC Pertuzumab Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Pertuzumab Revenue Market Share by Type (2018-2034)
Figure 67. APAC Pertuzumab Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Pertuzumab Revenue Market Share by Application (2018-2034)
Figure 69. APAC Pertuzumab Revenue Share by Region (2018-2034)
Figure 70. APAC Pertuzumab Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 75. India Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Pertuzumab Sales Quantity Market Share by Company in 2024
Figure 77. Middle East, Africa and Latin America Pertuzumab Revenue Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Pertuzumab Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Pertuzumab Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Pertuzumab Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Pertuzumab Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Pertuzumab Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Pertuzumab Revenue Share by Country (2018-2034)
Figure 84. Brazil Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Pertuzumab Revenue (2018-2034) & (US$ Million)
Figure 89. Pertuzumab Value Chain
Figure 90. Pertuzumab Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed